Search - tctmd.com

Displaying 321 - 340 of 1136

Sort: Relevancy | Date

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

January 07, 2022

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

News Daily News

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

Yael L. Maxwell

January 06, 2022

TCTMD’s Top 10 Most Popular Stories for December 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

December 29, 2021

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

Studies Zero in on Delayed Conduction Problems After TAVI

News Daily News

Studies Zero in on Delayed Conduction Problems After TAVI

December 21, 2021

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

New Scientific Statement Seeks to Standardize Cardiac Surgery Trials

News Daily News

New Scientific Statement Seeks to Standardize Cardiac Surgery Trials

Yael L. Maxwell

December 08, 2021

Statins Underprescribed in PAD Before and After Interventions

News Daily News

Statins Underprescribed in PAD Before and After Interventions

December 03, 2021

Penumbra’s JET 7 Recall: A Kick Start to Change?

News Daily News

Penumbra’s JET 7 Recall: A Kick Start to Change?

December 01, 2021

Point-of-Care hs-cTn Tests for MI Rule-out Could Save Time, Resources

News Daily News

Point-of-Care hs-cTn Tests for MI Rule-out Could Save Time, Resources

Yael L. Maxwell

December 01, 2021

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

November 01, 2021

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

November 01, 2021

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

October 29, 2021

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

October 28, 2021

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

News Daily News

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

October 27, 2021

Half-Dose DOAC May Be a Good Post-Watchman Option

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.